These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 26614510)

  • 1. Phospholipase C Beta 1: a Candidate Signature Gene for Proneural Subtype High-Grade Glioma.
    Lu G; Chang JT; Liu Z; Chen Y; Li M; Zhu JJ
    Mol Neurobiol; 2016 Nov; 53(9):6511-6525. PubMed ID: 26614510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta induced (TGFBI) is a potential signature gene for mesenchymal subtype high-grade glioma.
    Pan YB; Zhang CH; Wang SQ; Ai PH; Chen K; Zhu L; Sun ZL; Feng DF
    J Neurooncol; 2018 Apr; 137(2):395-407. PubMed ID: 29294230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas.
    Cooper LA; Gutman DA; Long Q; Johnson BA; Cholleti SR; Kurc T; Saltz JH; Brat DJ; Moreno CS
    PLoS One; 2010 Sep; 5(9):e12548. PubMed ID: 20838435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of phospholipase C β1 in glioblastoma: a study on the main mechanisms of tumor aggressiveness.
    Ratti S; Marvi MV; Mongiorgi S; Obeng EO; Rusciano I; Ramazzotti G; Morandi L; Asioli S; Zoli M; Mazzatenta D; Suh PG; Manzoli L; Cocco L
    Cell Mol Life Sci; 2022 Mar; 79(4):195. PubMed ID: 35303162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.
    Zhang C; Li J; Wang H; Song SW
    Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Periostin as a Potential Biomarker in Gliomas by Database Mining.
    Faried A; Hermanto Y; Tjahjono FP; Valentino A; Arifin MZ
    World Neurosurg; 2020 Mar; 135():e137-e163. PubMed ID: 31785437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA10 and CA11 negatively regulate neuronal activity-dependent growth of gliomas.
    Tao B; Ling Y; Zhang Y; Li S; Zhou P; Wang X; Li B; Jun Z; Zhang W; Xu C; Shi J; Wang L; Zhang W; Li S
    Mol Oncol; 2019 May; 13(5):1018-1032. PubMed ID: 30636076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3.
    Mao P; Joshi K; Li J; Kim SH; Li P; Santana-Santos L; Luthra S; Chandran UR; Benos PV; Smith L; Wang M; Hu B; Cheng SY; Sobol RW; Nakano I
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8644-9. PubMed ID: 23650391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and clinicopathologic characteristics of the molecular subtypes in malignant glioma: a multi-institutional analysis of 941 cases.
    Lin N; Yan W; Gao K; Wang Y; Zhang J; You Y
    PLoS One; 2014; 9(4):e94871. PubMed ID: 24755548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group.
    Yan W; Zhang W; You G; Zhang J; Han L; Bao Z; Wang Y; Liu Y; Jiang C; Kang C; You Y; Jiang T
    Neuro Oncol; 2012 Dec; 14(12):1432-40. PubMed ID: 23090983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma.
    Wang H; Jiang C
    Oncol Rep; 2013 Nov; 30(5):2350-6. PubMed ID: 24026199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma.
    Bourgonje AM; Verrijp K; Schepens JT; Navis AC; Piepers JA; Palmen CB; van den Eijnden M; Hooft van Huijsduijnen R; Wesseling P; Leenders WP; Hendriks WJ
    Acta Neuropathol Commun; 2016 Sep; 4(1):96. PubMed ID: 27586084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination genetic signature stratifies lower-grade gliomas better than histological grade.
    Chan AK; Yao Y; Zhang Z; Shi Z; Chen L; Chung NY; Liu JS; Li KK; Chan DT; Poon WS; Wang Y; Zhou L; Ng HK
    Oncotarget; 2015 Aug; 6(25):20885-901. PubMed ID: 26369702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of 5'-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness.
    Menezes WP; Silva VAO; Gomes INF; Rosa MN; Spina MLC; Carloni AC; Alves ALV; Melendez M; Almeida GC; Silva LSD; Clara C; da Cunha IW; Hajj GNM; Jones C; Bidinotto LT; Reis RM
    Cells; 2020 Feb; 9(2):. PubMed ID: 32093414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
    Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
    Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZIP4 is a novel molecular marker for glioma.
    Lin Y; Chen Y; Wang Y; Yang J; Zhu VF; Liu Y; Cui X; Chen L; Yan W; Jiang T; Hergenroeder GW; Fletcher SA; Levine JM; Kim DH; Tandon N; Zhu JJ; Li M
    Neuro Oncol; 2013 Aug; 15(8):1008-16. PubMed ID: 23595627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classifying lower grade glioma cases according to whole genome gene expression.
    Chen B; Liang T; Yang P; Wang H; Liu Y; Yang F; You G
    Oncotarget; 2016 Nov; 7(45):74031-74042. PubMed ID: 27677590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial cell transformation sequence 2 is a potential biomarker of unfavorable survival in human gliomas.
    Cheng YS; Lin C; Cheng YP; Yu YL; Tang CT; Hueng DY
    Neurol India; 2014; 62(4):406-9. PubMed ID: 25237947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
    Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
    EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prognostic Signature for Lower Grade Gliomas Based on Expression of Long Non-Coding RNAs.
    Kiran M; Chatrath A; Tang X; Keenan DM; Dutta A
    Mol Neurobiol; 2019 Jul; 56(7):4786-4798. PubMed ID: 30392137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.